An antipruritic agent for pruritus caused by multiple sclerosis. There is provided an antipruritic agent comprising as an active ingredient an opioid κ receptor agonist compound of specified chemical structure having a 4,5-epoxymorphinan skeleton, such as compound of the following structure, or a pharmacologically acceptable acid adduct thereof.